<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Immunol</journal-id><journal-id journal-id-type="iso-abbrev">J. Immunol</journal-id><journal-id journal-id-type="hwp">jimmunol</journal-id><journal-id journal-id-type="pmc">jimmunol</journal-id><journal-id journal-id-type="publisher-id">JI</journal-id><journal-title-group><journal-title>The Journal of Immunology Author Choice</journal-title></journal-title-group><issn pub-type="ppub">0022-1767</issn><issn pub-type="epub">1550-6606</issn><publisher><publisher-name>AAI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6121213</article-id><article-id pub-id-type="publisher-id">ji_1800704</article-id><article-id pub-id-type="doi">10.4049/jimmunol.1800704</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immune System Development</subject></subj-group></article-categories><title-group><article-title>ERK Signaling Controls Innate-like CD8<sup>+</sup> T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maurice</surname><given-names>Diane</given-names></name></contrib><contrib contrib-type="author"><name><surname>Costello</surname><given-names>Patrick</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sargent</surname><given-names>Mathew</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9658-0067</contrib-id><name><surname>Treisman</surname><given-names>Richard</given-names></name></contrib><aff id="aff1">Signalling and Transcription Group, The Francis Crick Institute, London NW1 1AT, United Kingdom</aff></contrib-group><author-notes><fn fn-type="con"><p>D.M. conceived, designed, performed, and interpreted experiments; P.C. constructed mouse strains and designed, performed, and interpreted experiments; M.S. constructed strains and performed experiments; R.T. conceived the project and designed and interpreted experiments; and D.M., P.C., and R.T. wrote the paper.</p></fn><corresp id="cor1">Address correspondence and reprint requests to Dr. Richard Treisman, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K. E-mail address: <email>Richard.Treisman@crick.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>1</day><month>8</month><year>2018</year></pub-date><volume>201</volume><issue>6</issue><fpage>1681</fpage><lpage>1691</lpage><history><date date-type="received"><day>18</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>07</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 The Authors</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Copyright &#x000a9; 2018 The Authors</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <underline><ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 Unported license</ext-link></underline>.</license-p></license></permissions><abstract><p>In mouse thymocyte development, signaling by the TCR through the ERK pathway is required for positive selection of conventional naive T cells. The Ets transcription factor ELK4 (SAP-1), an ERK-regulated cofactor of the SRF transcription factor, plays an important role in positive selection by activating immediate-early genes such as the Egr transcription factor family. The role of ELK4&#x02013;SRF signaling in development of other T cell types dependent on ERK signaling has been unclear. In this article, we show that ELK4, and its close relative ELK1, act cell autonomously in the thymus to control the generation of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells with memory-like characteristics. Mice lacking ELK4 and ELK1 develop increased numbers of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells, which populate the periphery. These cells develop cell autonomously rather than through expansion of PLZF<sup>+</sup> thymocytes and concomitantly increased IL-4 signaling. Their development is associated with reduced TCR-mediated activation of ELK4&#x02013;SRF target genes and can be partially suppressed by overexpression of the ELK4&#x02013;SRF target gene EGR2. Consistent with this, partial inhibition of ERK signaling in peripheral CD8<sup>+</sup>T cells promotes the generation of cells with innate-like characteristics. These data establish that low-level ERK signaling through ELK4 (and ELK1) promotes innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell differentiation, tuning conventional versus innate-like development.</p></abstract><counts><fig-count count="8"/><table-count count="0"/><equation-count count="0"/><ref-count count="39"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>During development of conventional &#x003b1;&#x003b2; T cells in the thymus, weak TCR signals ensure survival of non&#x02013;self-reactive thymocytes, whereas strong TCR signaling in self-reactive thymocytes drives their apoptotic elimination (reviewed by Ref. <xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref>). ERK signaling downstream of TCR engagement is essential for thymocyte positive selection but not for negative selection (<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r4" ref-type="bibr">4</xref>). TCR signaling is also important for development of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells, which express high levels of the Eomes transcription factor and which manifest effector functions immediately upon challenge (<xref rid="r5" ref-type="bibr">5</xref>&#x02013;<xref rid="r7" ref-type="bibr">7</xref>). For example, <italic>Itk</italic>-null and <italic>Slp76<sup>Y145F</sup></italic> mutations impair positive selection but increase innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell numbers (<xref rid="r8" ref-type="bibr">8</xref>&#x02013;<xref rid="r11" ref-type="bibr">11</xref>). At least in the case of Itk, these phenotypes reflect diminished ERK signaling (<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>), suggesting that weak ERK signaling from lower-affinity TCRs favors innate-like T cell development (reviewed by Ref. <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r7" ref-type="bibr">7</xref>).</p><p>The study of innate &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development is complicated because it can occur both cell autonomously and in response to cell-extrinsic cues. The latter includes IL-4, which is produced by cells expressing the PLZF transcription factor and influenced by the <italic>Itk</italic>, <italic>Klf2</italic>, <italic>Id3</italic>, <italic>Irf4</italic>, and <italic>Cbp</italic> genes, and lymphopenic conditions in the periphery (<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>; for review, see Ref. <xref rid="r14" ref-type="bibr">14</xref>). Nevertheless, the <italic>Nfkb1</italic> and <italic>Bcl11</italic> genes contribute cell autonomously to development of innate-like CD8+ T cells, whereas the effects of <italic>Itk</italic> and <italic>Irf4</italic> are at least partly cell autonomous (<xref rid="r15" ref-type="bibr">15</xref>&#x02013;<xref rid="r17" ref-type="bibr">17</xref>). <italic>Irf4</italic> is directly induced in response to TCR signaling in an Itk-dependent manner (<xref rid="r17" ref-type="bibr">17</xref>), but the relation of <italic>Nfkb1</italic> and <italic>Bcl11</italic> to TCR signaling remains to be elucidated.</p><p>The Ets domain transcription factors SAP-1/<italic>Elk4</italic> and Elk-1/<italic>Elk1</italic> are important nuclear effectors of TCR-induced ERK signaling, acting redundantly in partnership with their DNA-targeting partner SRF (for review, see Ref. <xref rid="r18" ref-type="bibr">18</xref>). Like the ERKs, ELK4/ELK1&#x02013;SRF signaling is required for positive but not negative selection (<xref rid="r19" ref-type="bibr">19</xref>&#x02013;<xref rid="r22" ref-type="bibr">22</xref>). Consistent with this, ELK4/ELK1&#x02013;SRF targets such as the <italic>Egr1</italic>, <italic>Egr2</italic>, <italic>Egr3</italic>, and <italic>Id3</italic> all promote positive selection (<xref rid="r23" ref-type="bibr">23</xref>&#x02013;<xref rid="r26" ref-type="bibr">26</xref>). These data are consistent with a model in which the efficiency of positive selection reflects the strength of ERK signaling to these genes (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref>).</p><p>Given the relationship between TCR signal strength and innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development, we set out to evaluate the contribution of ELK4 and ELK1. We demonstrate that ERK signaling to ELK4 and ELK1 acts to limit differentiation of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in the thymus and periphery, at least in part through expression of the ELK4&#x02013;SRF target <italic>Egr2</italic>. Dampening of the ERK signaling upstream of these factors similarly generates peripheral CD8<sup>+</sup> T cells with memory-like characteristics. Thus, in response to TCR signals, the ELK4&#x02013;SRF pathway is central to directing differentiation programs in &#x003b1;&#x003b2; CD8<sup>+</sup> T cells.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s3"><title>Animals and reagents</title><p>Mice were <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> and <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic> (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref>), carrying CD45.1 or CD45.2 alloantigen markers and the F5 TCR transgene (with <italic>Rag2</italic>-null background as specified in the text), and Egr2Tg and CD4Cre deleter (<xref rid="r25" ref-type="bibr">25</xref>). Young adult (6&#x02013;10 wk) age- and sex-matched animals were used in all experiments. For reconstitution, 8-to-10-wk-old female <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> mice watered on acidified water for 1 wk were irradiated (twice with 500 rad separated by 3-h interval), and bone marrow from the femurs of 6-to-8-wk-old donor mice (0.5&#x02013;1.0 &#x000d7; 10<sup>6</sup> cells) was injected into the tail vein. Analysis was performed 6 wk later. In some experiments, bone marrow was depleted of T cells and experimental (CD45.2<sup>+</sup>) cells were mixed with (CD45.1<sup>+</sup>CD45.2<sup>+</sup>) cells, and 5 &#x000d7; 10<sup>6</sup> cells were injected into lethally irradiated B6 SJL (CD45.1<sup>+</sup>) hosts, having received two 600-rad doses at a 3-h interval. Animals were maintained under specific-pathogen&#x02013;free conditions in the Crick Biological Resources Unit. Animal experimentation was approved by the Crick Animal Ethics committee and carried out under Home Office Procedure Project License 80/2602.</p></sec><sec id="s4"><title>Flow cytometry</title><p>For cell surface staining, cell suspensions were labeled with Abs in PBS, 1% FCS, 2 mM EDTA. For intracellular staining, cells were fixed and permeabilized using Foxp3 staining buffer kit (BD Biosciences) or the BD cytofix/cytoperm kit. For pERK staining, cells were fixed in 2% paraformaldehyde, washed and permeabilized in ice-cold methanol for 30 min, washed twice in PBS 10% FCS, and stained for 1 h. Samples were run on LSR-IIB or Fortessa II (BD Biosciences) and analyzed with FlowJo software (Free Star). An Aria III cell sorter (BD Biosciences) was used to isolate naive CD8 T cells at &#x0003e;97% purity as judged by cell surface marker expression. Coulter CC Size standard beads (Beckman Coulter) were used for calculating cell numbers. Abs were from eBioscience: CD8 (53-6.7), CD44 (IM7), CD122 (5H4), CXCR3 (173), CCR7 (4B12), NKG2D (CX5), CD45.1 (A20), Eomes (Dan11mag), T-bet (4B10), IL-4 (11B11), IFN-&#x003b3; (XMG1.2), TNF-&#x003b1; (MP6-XT22), and GranzymeB (NGZB); BD Biosciences: Bcl-2 (3F11), CD4 (RM4-5), &#x003b1;&#x003b2; TCR (&#x003b2;-chain. H57-597), heat stable Ag (HSA; M1/69), and pan ERK; BioLegend: CCL5 (2E9), PLZF (9E12), and IL-4R (I015F8); Santa Cruz Biotechnology: Egr1 (C19); and Cell Signaling Technology: pERK (p42/p44). mCD1d/PBS57 tetramers were generously supplied by the National Institute of Allergy and Infectious Disease MHC Tetramer Core Facility.</p></sec><sec id="s5"><title>Cell differentiation and stimulation</title><p>Sorted naive &#x003b1;&#x003b2; CD8<sup>+</sup> T cells were cultured for 2 h in RPMI 1640 containing 10% FCS, 50 &#x003bc;M 2-ME, and penicillin and streptomycin antibiotics (Sigma-Aldrich). For stimulation, 1 &#x000d7; 10<sup>6</sup> cells were spun (1500 rpm for 5 min) onto &#x003b1;CD3-coated (10 &#x003bc;g/ml) and &#x003b1;CD28-coated (10 &#x003bc;g/ml) 48-well plates washed in PBS and incubated at 37&#x000b0;C 10% CO<sub>2</sub> before analysis. For CD8<sup>+</sup> T effector differentiation cultures, cells were washed three times after stimulation and then cultured with 20 ng/ml recombinant IL-2 (ImmunoTools). For fetal thymic organ culture (FTOC), E15.5 fetal thymic lobes were cultured on Medicell membrane floated on IMDM/10% FCS, then disaggregated in accutase (PAA Laboratories) before FACS analysis. For intracellular cytokine staining, cells were stimulated with phorbol 12,13-dibutyrate (PDBu; 50 ng/ml) and ionomycin (1 &#x003bc;g/ml) (both Sigma-Aldrich) in the presence of Brefeldin A (5 &#x003bc;g/ml) (Sigma-Aldrich) for 5 h at 37&#x000b0;C before staining. For IL-4 intracellular staining, thymocyte suspensions were cultured for 1 h with 1.5 &#x003bc;M ionomycin and 50 ng/ml PMA (Sigma-Aldrich), then cultured for 2 h with the addition of Brefeldin A (5 &#x003bc;g/ml).</p></sec><sec id="s6"><title>Cell proliferation assays</title><p>To assess cell division kinetics, FACS-sorted &#x003b1;&#x003b2; CD8<sup>+</sup> T cells were stained with CFSE (5 &#x003bc;M; Molecular Probes) for 15 min in RPMI 1640 without serum, washed in 10% serum RPMI 1640 to stop the reaction, and subsequently plated with anti-CD3 and CD28 or NP68 peptide.</p></sec><sec id="s7"><title>Real-time PCR</title><p>Total RNA was extracted from sorted purified &#x003b1;&#x003b2; CD8<sup>+</sup> T cells using a GenElute mammalian total RNA kit (Sigma-Aldrich) and subjected to DNase I treatment (Ambion), and cDNA was generated using the Transcriptor cDNA synthetic kit (Roche). Target genes were analyzed using SYBR Green&#x02013;based real-time PCR (Invitrogen, Carlsbad, CA). Relative template cDNA abundance was calculated using standard curve method, normalizing to Rps16 cDNA, whose level was invariant under all conditions. Primers sequences are available upon request.</p></sec><sec id="s8"><title>Statistical analysis</title><p>Data were analyzed with Graph Pad Prism 6. Bar and dot charts are expressed as mean &#x000b1; SEM, and data were analyzed using the unpaired and paired parametric <italic>t</italic> test.</p></sec></sec><sec sec-type="results" id="s9"><title>Results</title><sec id="s10"><title>ELK4 and ELK1 inactivation increases numbers of thymic innate-like CD8<sup>+</sup> T cells</title><p>We investigated thymic innate-like T cell development in animals carrying previously characterized mutations in the SRF cofactors SAP-1/<italic>Elk4</italic> and Elk-1/<italic>Elk1</italic> (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref>). As previously reported, <italic>Elk4</italic>-null animals had reduced &#x003b1;&#x003b2; TCR<sup>hi</sup> single-positive (SP) frequency while maintaining the CD4:CD8 ratio, and this was enhanced by <italic>Elk1</italic> inactivation [<xref ref-type="fig" rid="fig01">Fig. 1A</xref> (<xref rid="r20" ref-type="bibr">20</xref>)]. However, analysis of mature <italic>Elk4</italic>-null CD8<sup>+</sup> TCR&#x003b2;<sup>high</sup> thymocytes revealed an increased proportion and absolute number of cells expressing markers associated with innate-like T cells, including the cell surface memory markers CD44 and CD122 (IL2R&#x003b2;) (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>, <xref ref-type="fig" rid="fig01">1B</xref>). Increased frequencies of cells expressing the inflammatory chemokine receptor CXCR3 and the memory cell transcription factor eomesodermin (Eomes) (<xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r28" ref-type="bibr">28</xref>) were also observed, and Eomes transcript levels were also increased (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>, <xref ref-type="fig" rid="fig01">1C</xref>). <italic>Elk4</italic>-null &#x003b1;&#x003b2; CD8<sup>+</sup> SP thymocytes appeared more mature than wild-type (WT) cells, exhibiting lower levels of HSA (CD24) (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>). All these phenotypes were exacerbated by additional deletion of Elk-1 (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>). The <italic>Elk4 Elk1</italic>&#x02013;null innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> SP thymocyte population expressed markers associated with conventional memory cells but not IL-4&#x02013;induced memory-like cells, such as NKG2D, T-bet, and CCL5 (<xref rid="r29" ref-type="bibr">29</xref>) (<xref ref-type="fig" rid="fig01">Fig. 1D</xref>).</p><fig id="fig01" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 1.</label><caption><p>Inactivation of <italic>Elk4</italic> and <italic>Elk1</italic> increases numbers of thymic innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells. (<bold>A</bold>) Top panels, TCR&#x003b2; staining in thymocytes isolated from 8-to-12-wk-old WT, <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic>, and <italic>Elk4<sup>&#x02212;/&#x02212;</sup>Elk-1<sup>&#x02212;/&#x02212;</sup></italic> female animals, with proportions of CD4 and CD8 in TCR&#x003b2;<sup>hi</sup>-gated thymocytes below. Lower panels, TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup>-gated thymocytes were stained for cell surface expression of CD44, CD122, CXCR3, HSA, and intracellular Eomes. Gated percentages are indicated. (<bold>B</bold>) Proportions (left) and absolute cell numbers (right) of TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup> CD122<sup>+</sup> innate T cells in WT, <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic>, and <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic> thymus. Data are representative of three independent staining experiments with &#x02265;5 animals per genotype. (<bold>C</bold>) Levels of Eomes mRNA transcripts in WT and <italic>Elk4<sup>&#x02212;/&#x02212;</sup>Elk1<sup>&#x02212;/&#x02212;</sup></italic> purified CD8<sup>+</sup> SP thymocytes, three animals per genotype. Data are representative of three independent experiments. (<bold>D</bold>) TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup>-gated WT and <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic> thymocytes were stained for cell surface expression of NKG2D, intracellular CCL5, and T-bet. Proportions of TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup> CD44<sup>+</sup> NKG2D<sup>+</sup>, CCL5<sup>+</sup>, or T-bet<sup>+</sup> cells are shown. <italic>n</italic> = 5 animals for each genotype; error bars represent SEM. Statistical significance: **<italic>p</italic> &#x0003c; 0.01, ***<italic>p</italic> &#x0003c; 0.001, ****<italic>p</italic> &#x0003c; 0.0001 (unpaired <italic>t</italic> test).</p></caption><graphic xlink:href="ji1800704f1"/></fig><p>We assessed the functionality of <italic>Elk4</italic>-null and <italic>Elk4 Elk1</italic>&#x02013;null &#x003b1;&#x003b2; CD8<sup>+</sup> TCR&#x003b2;<sup>hi</sup> thymocytes. Upon stimulation with PDBu and ionomycin, purified <italic>Elk4</italic>-null &#x003b1;&#x003b2; CD8<sup>+</sup> SP thymocytes produced substantially increased amounts of IFN-&#x003b3;, a heightened effector function associated with both memory and innate T cells (<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r28" ref-type="bibr">28</xref>) (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>). Furthermore, <italic>Elk4</italic>-null &#x003b1;&#x003b2; CD8<sup>+</sup> thymic T cells exhibited an enhanced sensitivity to TCR signal, as judged by their proliferative response under limiting activation conditions (<xref ref-type="fig" rid="fig02">Fig. 2B</xref>). To exclude the possibility that this reflects altered TCR repertoire, we also examined cells expressing a defined TCR. As with polyclonal &#x003b1;&#x003b2; CD8<sup>+</sup> thymic T cells, <italic>Elk4 Rag2</italic>&#x02013;null F5 transgenic thymic T cells also exhibited enhanced proliferation compared with their WT counterparts upon activation by F5 cognate NP68 peptide (<xref ref-type="fig" rid="fig02">Fig. 2C</xref>). Taken together, these observations are consistent with the idea that reduced ELK4&#x02013;SRF signaling promotes development of &#x003b1;&#x003b2; CD8<sup>+</sup> T cells with innate-like characteristics.</p><fig id="fig02" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 2.</label><caption><p>&#x003b1;&#x003b2; CD8<sup>+</sup> innate-like T cells have memory-like properties. (<bold>A</bold>) Purified &#x003b1;&#x003b2; TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup> SP thymocytes from <italic>Elk4<sup>+/&#x02212;</sup><italic>and</italic> Elk4<sup>&#x02212;/&#x02212;</sup></italic> thymus were activated with PDBu and ionomycin and stained for intracellular IFN-&#x003b3; 5 h later. Three animals per genotype; error bars represent SEM. Statistical significance: *<italic>p</italic> &#x0003c; 0.05 (unpaired <italic>t</italic> test). (<bold>B</bold>) Proliferation of CFSE-labeled FACS-sorted &#x003b1;&#x003b2; CD8<sup>+</sup> SP WT and <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> thymocytes stimulated by CD3/CD28 for 48 h. The percentage of divided cells is shown. Two independent experiments were performed. (<bold>C</bold>) Proliferation of CFSE-labeled FACS-sorted <italic>F5 Rag2<sup>&#x02212;/&#x02212;</sup></italic> and <italic>F5 Elk4<sup>&#x02212;/&#x02212;</sup>Rag2<sup>&#x02212;/&#x02212;</sup></italic> CD8<sup>+</sup> thymocytes 48 h following stimulation with NP68 peptide and irradiated splenocytes from C57BL6 (APCs). Two independent experiments were performed.</p></caption><graphic xlink:href="ji1800704f2"/></fig></sec><sec id="s11"><title>Innate-like CD8<sup>+</sup> T cells develop in the thymus</title><p>Activated and memory peripheral T cells can traffic to specific locations, including the thymus (<xref rid="r30" ref-type="bibr">30</xref>, <xref rid="r31" ref-type="bibr">31</xref>). The presence of innate-like cells in the thymus could reflect the altered homeostasis of peripheral CD8 T cells migrating back into the thymus because &#x003b1;&#x003b2; CD8<sup>+</sup> T cells with memory-like phenotypes are present in peripheral lymphoid organs (see below). To exclude this possibility, we analyzed 1-wk-old animals, in which mature T cells have not yet become established in secondary lymphoid organs. Increased numbers of innate-like cells expressing CD44, CD122, and Eomes were also observed in this setting in <italic>Elk4</italic>-null animals (<xref ref-type="fig" rid="fig03">Fig. 3A</xref>). Moreover, similar results were observed upon E15.5 <italic>Elk4</italic>&#x02013;null FTOC (<xref ref-type="fig" rid="fig03">Fig. 3B</xref>). Taken together, these results show that <italic>Elk4</italic> inactivation acts in the thymus to promote the generation of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells.</p><fig id="fig03" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 3.</label><caption><p>Innate CD8<sup>+</sup> T cells develop in the thymus. (<bold>A</bold>) Percentages of CD4 and CD8 cells in TCR&#x003b2;<sup>hi</sup> thymocytes isolated from P7 <italic>Elk4<sup>+/&#x02212;</sup></italic> and <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> littermates (top panels) and expression of CD44, CD122, and Eomes in TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup>-gated thymocytes (middle panels). Bottom, Proportions and absolute numbers of TCR&#x003b2;<sup>hi</sup> CD122<sup>+</sup> CD8<sup>+</sup> innate-like T cells. <italic>n</italic> &#x02265; 5 animals per genotype. (<bold>B</bold>) Profile of thymocytes stained with anti-CD4 and anti-CD8 from FTOC at day 8 (upper panel). Representative histogram of CD122 expression on TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup>-gated thymocytes from <italic>Elk4<sup>+/&#x02212;</sup></italic> (blue) and <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> (red) from day 8 FTOC (center panel). <italic>n</italic> &#x02265; 4 thymic lobes per genotype. Data are expressed as mean &#x000b1; SEM. Statistical significance: *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (unpaired <italic>t</italic> test).</p></caption><graphic xlink:href="ji1800704f3"/></fig></sec><sec id="s12"><title>Differentiation of Elk4-null innate-like CD8<sup>+</sup> T cells is cell autonomous</title><p>Innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells can develop either cell autonomously (<xref rid="r15" ref-type="bibr">15</xref>&#x02013;<xref rid="r17" ref-type="bibr">17</xref>) or in response to exogenous IL-4 produced by T cell subsets expressing the PLZF transcription factor (<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>). We used a mixed bone marrow chimera approach to address the issue more directly (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>). Irradiated CD45.1 WT host animals were reconstituted with WT bone marrow mixed with marrow from WT or <italic>Elk4</italic>-null animals in either a 4:1 or 1:4 ratio. Six weeks later, the relative contribution and phenotype of the adoptively transferred cells to the thymus population was evaluated, the donor populations being distinguished by their CD45.2 or CD45.1/2 surface markers. WT CD45.1/2 cells exhibited no difference in expression of the CD44, CD122, and HSA memory markers, regardless of whether the original transfer contained excess WT or <italic>Elk4</italic>-null cells (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>, <xref ref-type="fig" rid="fig04">4D</xref>, black versus blue). Similarly, <italic>Elk4</italic>-null CD45.2 thymocytes exhibited elevated innate-like marker expression regardless of whether they formed the minority or the majority of the transferred population (<xref ref-type="fig" rid="fig04">Fig. 4C</xref>, <xref ref-type="fig" rid="fig04">4D</xref>, red versus green, red versus blue). Similar results were obtained in <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> hosts reconstituted with mixed WT and <italic>Elk4</italic>-null bone marrow (<xref ref-type="supplementary-material" rid="DC1">Supplemental Fig. 1</xref>).</p><fig id="fig04" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 4.</label><caption><p><italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> &#x003b1;&#x003b2; CD8<sup>+</sup> innate-like T cell development in thymus is cell intrinsic. (<bold>A</bold>) Experimental strategy. Four groups of mixed bone marrow were transferred into irradiated CD45.1 hosts. Left panel, Each box indicates the majority and minority genotypes, with details given above, and experimental populations highlighted in color. Group 1: minority WT CD45.1/2 (20%, black), majority WT CD45.2 (80%). Group 2: minority WT CD45.1/2 (20%, blue), majority <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> CD45.2 (80%, green). Group 3: minority <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> CD45.2 (20%, red), majority WTCD45.1/2 (80%). Group 4: minority WTCD45.2 (20%, gray), majority WT CD45.1/2 (80%). Right panel, Level of chimerism in individual mice analyzed is represented for each group by a box-and-whiskers plot with minimum to maximum value. Each mouse is represented by two data points. (<bold>B</bold>) No bystander effects on minority population. Expression of CD44, CD122, and HSA on the minority TCR&#x003b2;<sup>hi</sup> CD8<sup>+</sup> populations in each group is shown. Black versus blue: no influence of majority <italic>Elk4</italic> genotype on WT cells. Red versus gray: <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> phenotype is detectable among majority WT cells. Black versus gray: no influence of CD45 allelic background. (<bold>C</bold>) Expression of CD44, CD122, and HSA on <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> cells among WT cells as the minority population (Group 3, red) or the majority population (Group 2, green). (<bold>D</bold>) Summary of results. Mean fluorescence intensity for CD44, CD122, and HSA for each population are color coded as in (A); comparisons made as in (B) and (C). Error bars represent SEM; <italic>n</italic> = 5 animals per group. Similar results were obtained when reconstitution was performed in <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> hosts (<xref ref-type="supplementary-material" rid="DC1">Supplemental Fig. 4</xref>). Statistical significance: ns, nonsignificant, *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01 (paired <italic>t</italic> test).</p></caption><graphic xlink:href="ji1800704f4"/></fig><p>We next investigated PLZF and CD1d expression in <italic>Elk4 Elk1</italic>&#x02013;null thymus. The proportions of thymocytes expressing PLZF or CD1d were not affected, but the absolute number of iNKT cells was increased in line with the increased thymic cellularity observed in <italic>Elk4 Elk1</italic>&#x02013;null mutant mice (<xref ref-type="fig" rid="fig05">Fig. 5A</xref>, <xref ref-type="fig" rid="fig05">5D</xref>). The intracellular induction levels of IL-4 after PMA/ionomycin stimulation were, however, significantly reduced in <italic>Elk4 Elk1</italic>&#x02013;null mice, both in total thymocytes (<xref ref-type="fig" rid="fig05">Fig. 5B</xref>) and in PLZF-gated and iNKT-gated thymocytes (<xref ref-type="fig" rid="fig05">Fig. 5C</xref>). Among individual PLZF-expressing thymocyte populations, the frequency of iNKT cells was unaffected, although their numbers increased, reflecting increased thymic cellularity (<xref ref-type="fig" rid="fig05">Fig. 5D</xref>), but the proportion of CD4<sup>+</sup> TCR&#x003b2;<sup>hi</sup> CD1-d tetramer-negative thymocytes was reduced (<xref ref-type="fig" rid="fig05">Fig. 5E</xref>). PLZF expression levels in both populations were unaffected (<xref ref-type="fig" rid="fig05">Fig. 5F</xref>). Taken together, these data show that generation of <italic>Elk4</italic>-null innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells is substantially cell autonomous and does not reflect alterations in PLZF expression and increased IL-4 expression.</p><fig id="fig05" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 5.</label><caption><p><italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> &#x003b1;&#x003b2; CD8<sup>+</sup> innate-like T cell development does not reflect increased PLZF or IL-4 expression. (<bold>A</bold>). PLZF and IL-4 expression are not increased by <italic>Elk4</italic> and <italic>Elk1</italic> inactivation. Top panels, Analysis of intracellular PLZF, TCR&#x003b2;, and CD1d expression in WT, <italic>Elk4</italic><sup>&#x02212;/&#x02212;</sup>, and <italic>Elk4</italic><sup>&#x02212;/&#x02212;</sup>
<italic>Elk1</italic><sup>&#x02212;/&#x02212;</sup> thymocytes (<italic>n</italic> = 7 per genotype). (<bold>B</bold>) Analysis of IL-4 and PLZF expression in unstimulated thymocytes (top panel) and PMA and ionomycin-stimulated thymocytes (bottom panel). (<bold>C</bold>) IL-4 expression in PLZF-gated and CD1d (iNKT)-gated populations (gray solid, unstimulated; black line, +PMA/ionomycin). PLZF-gated: WT, 33.17 &#x000b1; 3.835%; <italic>Elk4</italic><sup>&#x02212;/&#x02212;</sup>, 15.97 &#x000b1; 1.927%; <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic>, 9.377 &#x000b1; 0.3699%; <italic>n</italic> = 3, <italic>p</italic> &#x0003c; 0.01. iNKT-gated thymocytes: WT, 26.3 &#x000b1; 2.335%; <italic>Elk4</italic><sup>&#x02212;/&#x02212;</sup>, 12.9 &#x000b1; 1.68%; <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk-1<sup>&#x02212;/&#x02212;</sup></italic>, 8.527 &#x000b1; 0.5643%; <italic>n</italic> = 3, <italic>p</italic> &#x0003c; 0.01. (<bold>D</bold>) Proportions and cell numbers of iNKT cells in <italic>Elk4 Elk1</italic>&#x02013;null thymus. (<bold>E</bold>) Unchanged proportions of CD4 and CD8 cells in iNKT populations and <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic> TCR&#x003b2;<sup>hi</sup> CD1d<sup>&#x02212;</sup> cells. (<bold>F</bold>) PLZF expression levels are unchanged in <italic>Elk4<sup>&#x02212;/&#x02212;</sup> Elk1<sup>&#x02212;/&#x02212;</sup></italic> iNKT and TCR&#x003b2;<sup>hi</sup> CD4<sup>+</sup> CD1d<sup>&#x02212;</sup> cells. Data are expressed as mean &#x000b1; SEM. Statistical significance: **<italic>p</italic> &#x0003c; 0.01, ***<italic>p</italic> &#x0003c; 0.001 (unpaired <italic>t</italic> test).</p></caption><graphic xlink:href="ji1800704f5"/></fig></sec><sec id="s13"><title>Innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> cell development requires immediate-early gene expression</title><p>Studies in double-positive (DP) thymocytes have shown that TCR signaling to ELK4 and ELK1 activates the classical immediate-early gene set including Egr and AP1 family members (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref>). Quantitative RT-PCR confirmed that both in &#x003b1;&#x003b2; CD8<sup>+</sup> TCR&#x003b2;<sup>hi</sup> thymocytes and peripheral naive &#x003b1;&#x003b2; CD8<sup>+</sup> T cells, inactivation of <italic>Elk4</italic> led to reduced transcription of classical immediate-early genes at early times following TCR cross-linking (<xref ref-type="fig" rid="fig06">Fig. 6A</xref>, <xref ref-type="fig" rid="fig06">6B</xref>). We previously showed that ectopic expression of Egr family members could rescue the positive selection defect in <italic>Elk4</italic>-null animals (<xref rid="r20" ref-type="bibr">20</xref>). To test the role of ELK4&#x02013;SRF target genes in innate-like T cell development, we used a conditional transgene approach to express EGR2 in DP thymocytes (<xref rid="r25" ref-type="bibr">25</xref>). <italic>Egr2</italic> expression partially rescued the positive selection defect in <italic>Elk4</italic>-null animals, reducing the proportion of CD44<sup>hi</sup> CD122<sup>hi</sup> CD8<sup>+</sup> thymocytes and Eomes expression levels (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>). These data are consistent with a role for EGR2 and potentially other Egr family members or other ELK4&#x02013;SRF targets in development of innate-like CD8<sup>+</sup> T cells in the thymus.</p><fig id="fig06" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 6.</label><caption><p>Reduced immediate-early gene expression is associated with innate-like CD8<sup>+</sup> T cell development. (<bold>A</bold>) CD8 SP TCR&#x003b2;<sup>hi</sup> thymocytes and (<bold>B</bold>) peripheral CD8 SP CD44<sup>lo</sup> CD122<sup>lo</sup> cells were activated using &#x003b1;CD3 and &#x003b1;CD28, and expression of <italic>Egr1</italic> and <italic>Egr2</italic> at the indicated times was analyzed by quantitative RT-PCR. (<bold>C</bold>) <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> animals were reconstituted either with bone marrow from animals carrying a conditional EGR2 transgene, along with a CD4-Cre transgene to allow expression of EGR2 at the DP stage of thymocyte development, with bone marrow from <italic>Elk4<sup>&#x02212;/&#x02212;</sup> CD4-Cre</italic>, or a combination of these genotypes. TCR &#x003b2;<sup>hi</sup> CD8 thymocytes were analyzed for CD44, CD122, and intracellular Eomesodermin as in <xref ref-type="fig" rid="fig01">Fig. 1</xref>. Error bars represent SEM; <italic>n</italic> &#x02265; 5 animals per group. Statistical significance: ****<italic>p</italic> &#x0003c; 0.0001 (unpaired <italic>t</italic> test).</p></caption><graphic xlink:href="ji1800704f6"/></fig></sec><sec id="s14"><title>Innate-like Elk4-null CD8<sup>+</sup> T cells accumulate in the periphery</title><p>We next investigated whether <italic>Elk4</italic> inactivation affected accumulation of innate-like T cells in the periphery. Increased numbers of CD44<sup>hi</sup> CD122<sup>hi</sup> &#x003b1;&#x003b2; CD8<sup>+</sup> T cells, expressing higher levels of Eomes transcripts, were present in the lymph nodes and spleens of <italic>Elk4</italic>- and <italic>Elk4 Elk1</italic>&#x02013;null animals (<xref ref-type="fig" rid="fig07">Fig. 7A</xref>). Similar to &#x003b1;&#x003b2; CD8<sup>+</sup> SP thymocytes, these cells produced more IFN-&#x003b3; after short stimulation and exhibited enhanced sensitivity in response to TCR signaling, as detected by tritiated thymidine incorporation and CFSE staining (<xref ref-type="supplementary-material" rid="DC1">Supplemental Fig. 2</xref>). <italic>Elk4</italic>-null mice are defective in thymocyte positive selection and exhibit lymphopenia (<xref rid="r19" ref-type="bibr">19</xref>), which can promote differentiation of memory-like CD8<sup>+</sup> T cells in the periphery (<xref rid="r14" ref-type="bibr">14</xref>). To exclude this possibility, we analyzed peripheral T cells in animals reconstituted with equal proportions of <italic>Elk4</italic>-null and WT bone marrow. Again, both lymph nodes and spleen in these animals contained elevated proportions of <italic>Elk4</italic>-null CD44<sup>hi</sup> CD122<sup>hi</sup> &#x003b1;&#x003b2; CD8<sup>+</sup> T cells that expressed Eomes transcripts at a high level (<xref ref-type="fig" rid="fig07">Fig. 7B</xref>) and that produced high levels of IFN-&#x003b3; following stimulation with PDBu and ionomycin (<xref ref-type="fig" rid="fig07">Fig. 7C</xref>). Elevated numbers of thymic and peripheral innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells were also detected in mixed reconstitutions with <italic>Elk4</italic>-null cells expressing the MHC class I&#x02013;specific F5 TCR (<xref ref-type="supplementary-material" rid="DC1">Supplemental Fig. 3</xref>) and so are unlikely to arise because of altered TCR repertoire in <italic>Elk4</italic>-null animals. These results suggest that the increased number of peripheral memory-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells is not a result of lymphopenia in <italic>Elk4</italic>-null animals.</p><fig id="fig07" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 7.</label><caption><p>Peripheral &#x003b1;&#x003b2; CD8<sup>+</sup> memory-like T cells in <italic>Elk4</italic>-null animals do not arise through lymphopenia-induced proliferation. (<bold>A</bold>) Increased proportions and numbers of CD44<sup>+</sup> CD122<sup>+</sup> CD8 T cells in lymph nodes and spleen of primary animals. Levels of Eomes transcripts in purified CD8<sup>+</sup> lymph node (LN) T cells. (<bold>B</bold>) Analysis of CD8<sup>+</sup> T cells from <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> hosts reconstituted with WT CD45.1 and <italic>Elk4<sup>&#x02212;/&#x02212;</sup></italic> CD45.2 bone marrow at 1:1 ratio. Increased proportions of CD44<sup>+</sup> CD122<sup>+</sup> CD8<sup>+</sup> SP T cells in thymus (TH; WT, 0.53 &#x000b1; 0.23%; <italic>Elk4 <sup>&#x02212;/&#x02212;</sup></italic>, 1.34 &#x000b1; 0.47%; 10 mice each), LN, and spleen (SP) (<italic>n</italic> &#x02265; 8 mice). Right, Increased expression of Eomes transcripts in <italic>Elk4 <sup>&#x02212;/&#x02212;</sup></italic> sorted LN CD8<sup>+</sup> cells. (<bold>C</bold>) Left, Representative flow cytometry plots of intracellular production of IFN-&#x003b3; in LN CD8<sup>+</sup> T cells from animals reconstituted as in (B) after stimulation with PDBu and ionomycin. Right, Data summary (<italic>n</italic> = 6). Data are expressed as mean &#x000b1; SEM. Statistical significance: *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01, ***<italic>p</italic> &#x0003c; 0.001, ****<italic>p</italic> &#x0003c; 0.0001 [unpaired (A) and paired (B and C) Student <italic>t</italic> test].</p></caption><graphic xlink:href="ji1800704f7"/></fig></sec><sec id="s15"><title>Reduced ERK signaling in peripheral T cells promotes development of cell with innate-like properties</title><p>We next investigated whether memory-like CD8 T cells could be generated de novo in the periphery. Previous work has shown that weak TCR signals in peripheral CD8<sup>+</sup> T cells, generated by interaction with self-peptide/MHC, promote the differentiation into innate-like cells with memory characteristics (reviewed by Ref. <xref rid="r14" ref-type="bibr">14</xref>). Our results suggest a model in which <italic>Elk4</italic> inactivation effectively decreases ERK signaling to transcription downstream of the TCR, so we tested whether directly decreasing ERK signaling to ELK4 in WT peripheral cells would increase their differentiation into memory-like cells. We used a system in which naive T cells are subjected to TCR cross-linking in vitro, followed by culture in IL-2; this treatment induces T bet and Eomes expression and causes them to produce IFN-&#x003b3; and TNF immediately upon subsequent TCR restimulation (<xref rid="r32" ref-type="bibr">32</xref>). F5 <italic>Rag2</italic>&#x02013;null CD8<sup>+</sup> T cells were used to study the response of cells expressing a defined TCR.</p><p>Inclusion of the MEK inhibitor U0126 during the initial TCR ligation phase progressively limited both ERK activation and <italic>Egr1</italic> expression (<xref ref-type="fig" rid="fig08">Fig. 8A</xref>). Submaximal concentrations of U0126 reduced T-bet expression at early times of IL-2 culture and increased Eomes expression at late times (<xref ref-type="fig" rid="fig08">Fig. 8B</xref>). After prolonged culture in IL-2, U0126-treated F5 &#x003b1;&#x003b2; CD8<sup>+</sup> T cells exhibited increased production of IFN-&#x003b3; and granzyme B upon stimulation with PDBu and ionomycin (<xref ref-type="fig" rid="fig08">Fig. 8C</xref>). Similar results were obtained when we examined purified naive CD44<sup>lo</sup>
<italic>Elk4</italic>-null &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in this assay (<xref ref-type="supplementary-material" rid="DC1">Supplemental Fig. 4A</xref>). Experiments with T cells expressing the F5 TCR showed that these changes were also dependent on SRF, the targeting partner protein for ELK4 (data not shown). Together, these data are consistent with a model in which decreased ERK signaling to ELK4 target genes in peripheral or thymic &#x003b1;&#x003b2; CD8<sup>+</sup> T cells favors the development of T cells with memory-like characteristics (<xref ref-type="fig" rid="fig08">Fig. 8D</xref>).</p><fig id="fig08" fig-type="figure" orientation="portrait" position="float"><label>FIGURE 8.</label><caption><p>Inhibition of ERK signaling promotes differentiation of naive peripheral &#x003b1;&#x003b2; CD8<sup>+</sup> T cells into cells with memory-like characteristics. (<bold>A</bold>) Differentiation of naive WT F5 <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> CD8<sup>+</sup> T cells. Peripheral CD8<sup>+</sup> T cells were activated for 2 d with anti-CD3/anti-CD28 (10 &#x003bc;g/ml), with or without U0126 addition, and then cultured in IL-2 as indicated. Intracellular activated phospho-ERK (top) or Egr-1 protein (bottom) following anti-CD3 and anti-CD28 activation. Gray shading, isotype control; color-coded lines, WT F5 <italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> cells according to U0126 concentration. (<bold>B</bold>) Expression of Eomes and T-bet. Top, Quantitative RT-PCR analysis. Bottom, Flow cytometric analysis of protein levels. (<bold>C</bold>) Flow cytometric analysis of intracellular IFN-&#x003b3; and granzyme B expression after PDBu/ionomycin activation for 5 h. Data are representative of six (A&#x02013;C) independent experiments, each done in triplicate. Data are mean &#x000b1; SEM. Statistical significance: ***<italic>p</italic> &#x0003c; 0.001 (unpaired <italic>t</italic> test). (<bold>D</bold>) Summary of the relationship between MHC-peptide&#x02013;TCR avidity, activation of TCF-SRF target genes, and cell differentiation pathways in thymus and periphery. Inactivation of ERK-ELK4/ELK1&#x02013;SRF signaling in thymocytes and in peripheral &#x003b1;&#x003b2; CD8<sup>+</sup> T cells favors the development of cells with innate-like characteristics, which exhibit enhanced Eomes expression and immediate production of IFN-&#x003b3;.</p></caption><graphic xlink:href="ji1800704f8"/></fig></sec></sec><sec sec-type="discussion" id="s16"><title>Discussion</title><p>TCR signaling to transcription via the Ets protein ELK4 (SAP-1), its relative ELK1, and their partner transcription factor SRF is critical for thymocyte positive selection (<xref rid="r19" ref-type="bibr">19</xref>&#x02013;<xref rid="r22" ref-type="bibr">22</xref>). In this study, we have shown that ELK4 and ELK1 act redundantly and cell autonomously downstream of ERK signaling to limit the generation of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells with memory characteristics in the thymus. These cells exhibit hallmarks of conventional memory CD8<sup>+</sup> T cells, with enhanced expression of the T-box transcription factors Eomes and T-bet and increased proliferation and production of IFN-&#x003b3; in response to TCR ligation (<xref rid="r27" ref-type="bibr">27</xref>&#x02013;<xref rid="r29" ref-type="bibr">29</xref>). The effect of ELK4 inactivation is unlikely to reflect a change in TCR repertoire that preferentially selects innate-like cells because increased innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> differentiation occurred in <italic>Elk4</italic>-null cells expressing the MHC class I&#x02013;specific F5 TCR. Moreover, innate-like cells were also present in neonatal and embryonic animals, in which the TCR repertoire is limited (<xref rid="r33" ref-type="bibr">33</xref>). Like other ELK4 phenotypes, generation of innate-like CD8+ T cells was further enhanced by additional inactivation of <italic>Elk1</italic>. Transgenic expression of the ELK4 target gene <italic>Egr2</italic> reduced the innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development in <italic>Elk4</italic>-null animals and rescued the positive selection defect. Our results are consistent with the proposal that innate-like differentiation is favored by low TCR signal strength (<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r7" ref-type="bibr">7</xref>) (<xref ref-type="fig" rid="fig08">Fig. 8D</xref>).</p><p>We used a chimeric reconstitution approach to show that ELK4 acts cell autonomously in innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell formation and that this is associated with increased Eomes expression. Innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell formation is also controlled cell autonomously by <italic>Nfkb1</italic> (<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r34" ref-type="bibr">34</xref>) and <italic>Bcl11b</italic> (<xref rid="r15" ref-type="bibr">15</xref>), and <italic>Irf4</italic> acts partly cell autonomously (<xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r35" ref-type="bibr">35</xref>). Previous work has demonstrated that generation of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in the thymus and periphery can also be induced by cell-extrinsic pathways. Genes, such as <italic>Itk</italic>, <italic>Klf2</italic>, <italic>Id3</italic>, and <italic>Cbp</italic>, influence innate-like T cell development by increasing levels of IL-4, produced by elevated numbers of PLZF<sup>+</sup> cells such as iNKT and CD4<sup>+</sup> TCR&#x003b2;<sup>hi</sup> cells (<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>, reviewed by Ref. <xref rid="r14" ref-type="bibr">14</xref>). However, we found that proportions of iNKT cells were unchanged in <italic>Elk4 Elk1</italic>&#x02013;null thymocytes, whereas CD4<sup>+</sup> TCR&#x003b2;<sup>hi</sup> cells were decreased, and PZLF expression levels were unchanged in both cell subsets. Moreover, innate-like thymic &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in <italic>Elk4</italic>-null animals expressed markers associated with conventional or lymphopenia-induced memory cells but not IL4-induced memory. IL-4 production in total PLZF<sup>+</sup> and iNKT<sup>+</sup> thymocytes was reduced in <italic>Elk4</italic> null animals and further reduced in <italic>Elk4 Elk1</italic>&#x02013;null thymocytes. Thus, IL4 signaling cannot account for the increased innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> thymocyte differentiation that we observe in Elk4-null animals.</p><p>Several studies suggest that in addition to promoting positive selection, TCR signaling controls development of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells (reviewed by Ref. <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r7" ref-type="bibr">7</xref>). Both <italic>Itk</italic>-null (<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>) and mutant <italic>Slp76<sup>Y145F</sup></italic> (<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r11" ref-type="bibr">11</xref>) thymocytes exhibit impaired positive selection and increased innate &#x003b1;&#x003b2; CD8<sup>+</sup> T cell numbers. Moreover, these phenotypes can be partially suppressed by expression of the hypersensitive ERK<sup>sem</sup> protein, suggesting they are directly controlled by ERK signaling (<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>). Consistent with this idea, we found that inhibition of ERK signaling promoted the differentiation of cultured peripheral T cells to a memory-like phenotype upon TCR ligation and culture in IL2.</p><p>The genomic targets of ELK4&#x02013;SRF signaling include members of the AP-1 and Egr transcription factor families. We found that transgenic expression of EGR2 suppressed development of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in Elk4-null thymus, suggesting that EGR2 or other Egr family members act downstream of ELK4; however, it is likely that other ELK4&#x02013;SRF target genes may be involved because the suppression observed was incomplete. Interestingly, inactivation of Id3, an ERK-responsive Egr target gene (<xref rid="r36" ref-type="bibr">36</xref>), also increases innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development but does not do so cell autonomously (<xref rid="r12" ref-type="bibr">12</xref>). Moreover, unlike ELK4, Id3 inactivation impairs both positive and negative selection (<xref rid="r26" ref-type="bibr">26</xref>). Together, these observations indicate that loss of Id3 expression downstream of ELK4 cannot be responsible for innate &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development in <italic>Elk4</italic>-null animals.</p><p>Our data show that ELK4, a major nuclear ERK target in thymocytes, acts downstream of ERK signaling to suppress innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development, acting via target genes such as <italic>Egr2</italic>. We propose that inactivation of <italic>Elk4</italic> attenuates TCR signaling, thereby effectively mimicking low-affinity TCR signaling, leading to increased numbers of innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cells in addition to impairing positive selection. We note that ITK signaling acts upstream of SRF (<xref rid="r37" ref-type="bibr">37</xref>) and that inhibition of ITK signaling potentiates the effect of <italic>Irf4</italic> inactivation on innate-like &#x003b1;&#x003b2; CD8<sup>+</sup> T cell development (<xref rid="r17" ref-type="bibr">17</xref>). This suggests that the ELK4&#x02013;SRF and IRF4 pathways might cooperate, and, indeed, Irf4 protein levels, but not transcripts, are reduced in <italic>Elk4</italic>-null thymus (D. Maurice, unpublished observation). It is interesting to note that AP1 [whose components, such as <italic>JunB,</italic> are <italic>Elk4</italic> target genes in T cells (<xref rid="r20" ref-type="bibr">20</xref>)] functionally cooperates with IRF4 (<xref rid="r38" ref-type="bibr">38</xref>, <xref rid="r39" ref-type="bibr">39</xref>).</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="DC1"><label>Data Supplement</label><media id="d35e150" xlink:href="JI_1800704.zip"/></supplementary-material></sec></body><back><ack><p>We thank Adrian Hayday, Caetano Reis e Sousa, Jacqueline Marvel, and laboratory members for helpful discussions, suggestions, and comments on the manuscript; Derek Davies and the Francis Crick Institute FACS facility for flow cytometry; and Clare Watkins and Tom Childs from Biological Resources for expert support.</p></ack><fn-group><fn id="grant" fn-type="supported-by"><p>This work was supported by Cancer Research UK core funding until March 31, 2015, and since then, work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001-190), the United Kingdom Medical Research Council (FC001-190), and the Wellcome Trust (FC001-190). R.T. acknowledges support from the European Research Council (Advanced Grant 268690).</p></fn><fn id="supp" fn-type="supplementary-material"><p>The online version of this article contains <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1800704/-/DCSupplemental">supplemental material</ext-link>.</p></fn></fn-group><fn-group content-type="abbreviations"><fn id="abbr" fn-type="abbr"><p>Abbreviations used in this article:<def-list><def-item><term id="G1">DP</term><def><p>double-positive</p></def></def-item><def-item><term id="G2">FTOC</term><def><p>fetal thymic organ culture</p></def></def-item><def-item><term id="G3">HSA</term><def><p>heat stable Ag</p></def></def-item><def-item><term id="G4">PDBu</term><def><p>phorbol 12,13-dibutyrate</p></def></def-item><def-item><term id="G5">SP</term><def><p>single-positive</p></def></def-item><def-item><term id="G6">WT</term><def><p>wild-type.</p></def></def-item></def-list></p></fn></fn-group><sec id="s17" sec-type="financial-disclosure"><title>Disclosures</title><p>The authors have no financial conflicts of interest.</p></sec><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gascoigne</surname><given-names>N. R.</given-names></name><name name-style="western"><surname>Rybakin</surname><given-names>V.</given-names></name><name name-style="western"><surname>Acuto</surname><given-names>O.</given-names></name><name name-style="western"><surname>Brzostek</surname><given-names>J.</given-names></name></person-group>
<year>2016</year>
<article-title>TCR signal strength and T cell development.</article-title>
<source>Annu. Rev. Cell Dev. Biol.</source>
<volume>32</volume>: <fpage>327</fpage>&#x02013;<lpage>348</lpage>.<pub-id pub-id-type="pmid">27712102</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starr</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Jameson</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Hogquist</surname><given-names>K. A.</given-names></name></person-group>
<year>2003</year>
<article-title>Positive and negative selection of T cells.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>21</volume>: <fpage>139</fpage>&#x02013;<lpage>176</lpage>.<pub-id pub-id-type="pmid">12414722</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Pag&#x000e8;s</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pouyss&#x000e9;gur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>S. M.</given-names></name></person-group>
<year>2005</year>
<article-title>The role of erk1 and erk2 in multiple stages of T cell development.</article-title>
<source>Immunity</source>
<volume>23</volume>: <fpage>431</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">16226508</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGargill</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Ch&#x02019;en</surname><given-names>I. L.</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Pag&#x000e8;s</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pouyss&#x000e9;gur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>S. M.</given-names></name></person-group>
<year>2009</year>
<article-title>Cutting edge: extracellular signal-related kinase is not required for negative selection of developing T cells.</article-title>
<source>J. Immunol.</source>
<volume>183</volume>: <fpage>4838</fpage>&#x02013;<lpage>4842</lpage>.<pub-id pub-id-type="pmid">19801509</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berg</surname><given-names>L. J.</given-names></name></person-group>
<year>2007</year>
<article-title>Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development.</article-title>
<source>Nat. Rev. Immunol.</source>
<volume>7</volume>: <fpage>479</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">17479128</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prince</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Enos</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Felices</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L. J.</given-names></name></person-group>
<year>2009</year>
<article-title>The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.</article-title>
<source>Immunol. Rev.</source>
<volume>228</volume>: <fpage>115</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">19290924</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Readinger</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>K. L.</given-names></name><name name-style="western"><surname>Venegas</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Horai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schwartzberg</surname><given-names>P. L.</given-names></name></person-group>
<year>2009</year>
<article-title>Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.</article-title>
<source>Immunol. Rev.</source>
<volume>228</volume>: <fpage>93</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">19290923</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atherly</surname><given-names>L. O.</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Welsh</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L. J.</given-names></name></person-group>
<year>2006</year>
<article-title>Tec kinases Itk and Rlk are required for CD8+ T cell responses to virus infection independent of their role in CD4+ T cell help.</article-title>
<source>J. Immunol.</source>
<volume>176</volume>: <fpage>1571</fpage>&#x02013;<lpage>1581</lpage>.<pub-id pub-id-type="pmid">16424186</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broussard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fleischacker</surname><given-names>C.</given-names></name><name name-style="western"><surname>Horai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chetana</surname><given-names>M.</given-names></name><name name-style="western"><surname>Venegas</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>L. L.</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Fowlkes</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Schwartzberg</surname><given-names>P. L.</given-names></name></person-group>
<year>2006</year>
<article-title>Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. [Published erratum appears in 2006 <italic>Immunity</italic> 25: 849.]</article-title>
<source>Immunity</source>
<volume>25</volume>: <fpage>93</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">16860760</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jordan</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Austin</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>K. E.</given-names></name><name name-style="western"><surname>Aschenbrenner</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Koretzky</surname><given-names>G. A.</given-names></name></person-group>
<year>2008</year>
<article-title>Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76.</article-title>
<source>Immunity</source>
<volume>28</volume>: <fpage>359</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">18342008</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith-Garvin</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Gohil</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Maltzman</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Koretzky</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Jordan</surname><given-names>M. S.</given-names></name></person-group>
<year>2010</year>
<article-title>T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool.</article-title>
<source>Blood</source>
<volume>116</volume>: <fpage>5548</fpage>&#x02013;<lpage>5559</lpage>.<pub-id pub-id-type="pmid">20847203</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verykokakis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Boos</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Bendelac</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kee</surname><given-names>B. L.</given-names></name></person-group>
<year>2010</year>
<article-title>SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics.</article-title>
<source>Immunity</source>
<volume>33</volume>: <fpage>203</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">20674402</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinreich</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Odumade</surname><given-names>O. A.</given-names></name><name name-style="western"><surname>Jameson</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Hogquist</surname><given-names>K. A.</given-names></name></person-group>
<year>2010</year>
<article-title>T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells.</article-title>
<source>Nat. Immunol.</source>
<volume>11</volume>: <fpage>709</fpage>&#x02013;<lpage>716</lpage>.<pub-id pub-id-type="pmid">20601952</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jameson</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Hogquist</surname><given-names>K. A.</given-names></name></person-group>
<year>2015</year>
<article-title>Innate memory T cells.</article-title>
<source>Adv. Immunol.</source>
<volume>126</volume>: <fpage>173</fpage>&#x02013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">25727290</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirose</surname><given-names>S.</given-names></name><name name-style="western"><surname>Touma</surname><given-names>M.</given-names></name><name name-style="western"><surname>Go</surname><given-names>R.</given-names></name><name name-style="western"><surname>Katsuragi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sakuraba</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gondo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Abe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sakimura</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mishima</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kominami</surname><given-names>R.</given-names></name></person-group>
<year>2015</year>
<article-title>Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.</article-title>
<source>Int. Immunol.</source>
<volume>27</volume>: <fpage>205</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">25422283</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gugasyan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Horat</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kinkel</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>F.</given-names></name><name name-style="western"><surname>Grigoriadis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>D.</given-names></name><name name-style="western"><surname>O&#x02019;Keeffe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berzins</surname><given-names>S. P.</given-names></name><name name-style="western"><surname>Belz</surname><given-names>G. T.</given-names></name><name name-style="western"><surname>Grumont</surname><given-names>R. J.</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>The NF-&#x003ba;B1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.</article-title>
<source>EMBO J.</source>
<volume>31</volume>: <fpage>692</fpage>&#x02013;<lpage>706</lpage>.<pub-id pub-id-type="pmid">22124325</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nayar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Enos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hemmers</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J. K.</given-names></name><name name-style="western"><surname>Klein</surname><given-names>U.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L. J.</given-names></name></person-group>
<year>2012</year>
<article-title>TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>109</volume>: <fpage>E2794</fpage>&#x02013;<lpage>E2802</lpage>.<pub-id pub-id-type="pmid">23011795</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Posern</surname><given-names>G.</given-names></name><name name-style="western"><surname>Treisman</surname><given-names>R.</given-names></name></person-group>
<year>2006</year>
<article-title>Actin&#x02019; together: serum response factor, its cofactors and the link to signal transduction.</article-title>
<source>Trends Cell Biol.</source>
<volume>16</volume>: <fpage>588</fpage>&#x02013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">17035020</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costello</surname><given-names>P. S.</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>R. H.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rosewell</surname><given-names>I.</given-names></name><name name-style="western"><surname>Treisman</surname><given-names>R.</given-names></name></person-group>
<year>2004</year>
<article-title>Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection.</article-title>
<source>Nat. Immunol.</source>
<volume>5</volume>: <fpage>289</fpage>&#x02013;<lpage>298</lpage>.<pub-id pub-id-type="pmid">14770179</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costello</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Willoughby</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wasylyk</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nordheim</surname><given-names>A.</given-names></name><name name-style="western"><surname>Treisman</surname><given-names>R.</given-names></name></person-group>
<year>2010</year>
<article-title>Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development.</article-title>
<source>J. Immunol.</source>
<volume>185</volume>: <fpage>1082</fpage>&#x02013;<lpage>1092</lpage>.<pub-id pub-id-type="pmid">20554967</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mylona</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Maurice</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sargent</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tuil</surname><given-names>D.</given-names></name><name name-style="western"><surname>Daegelen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Treisman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Costello</surname><given-names>P.</given-names></name></person-group>
<year>2011</year>
<article-title>The essential function for serum response factor in T-cell development reflects its specific coupling to extracellular signal-regulated kinase signaling.</article-title>
<source>Mol. Cell. Biol.</source>
<volume>31</volume>: <fpage>267</fpage>&#x02013;<lpage>276</lpage>.<pub-id pub-id-type="pmid">21098124</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleige</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gr&#x000f6;be</surname><given-names>L.</given-names></name><name name-style="western"><surname>Frischmann</surname><given-names>U.</given-names></name><name name-style="western"><surname>Geffers</surname><given-names>R.</given-names></name><name name-style="western"><surname>M&#x000fc;ller</surname><given-names>W.</given-names></name><name name-style="western"><surname>Nordheim</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schippers</surname><given-names>A.</given-names></name></person-group>
<year>2007</year>
<article-title>Serum response factor contributes selectively to lymphocyte development.</article-title>
<source>J. Biol. Chem.</source>
<volume>282</volume>: <fpage>24320</fpage>&#x02013;<lpage>24328</lpage>.<pub-id pub-id-type="pmid">17591768</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauritsen</surname><given-names>J.-P. H.</given-names></name><name name-style="western"><surname>Kurella</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.-Y.</given-names></name><name name-style="western"><surname>Lefebvre</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Rhodes</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alberola-Ila</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wiest</surname><given-names>D. L.</given-names></name></person-group>
<year>2008</year>
<article-title>Egr2 is required for Bcl-2 induction during positive selection.</article-title>
<source>J. Immunol.</source>
<volume>181</volume>: <fpage>7778</fpage>&#x02013;<lpage>7785</lpage>.<pub-id pub-id-type="pmid">19017967</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Milbrandt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kersh</surname><given-names>G. J.</given-names></name></person-group>
<year>2002</year>
<article-title>Thymocyte development in early growth response gene 1-deficient mice.</article-title>
<source>J. Immunol.</source>
<volume>169</volume>: <fpage>1713</fpage>&#x02013;<lpage>1720</lpage>.<pub-id pub-id-type="pmid">12165491</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawson</surname><given-names>V. J.</given-names></name><name name-style="western"><surname>Weston</surname><given-names>K.</given-names></name><name name-style="western"><surname>Maurice</surname><given-names>D.</given-names></name></person-group>
<year>2010</year>
<article-title>Early growth response 2 regulates the survival of thymocytes during positive selection.</article-title>
<source>Eur. J. Immunol.</source>
<volume>40</volume>: <fpage>232</fpage>&#x02013;<lpage>241</lpage>.<pub-id pub-id-type="pmid">19877014</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivera</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Johns</surname><given-names>C. P.</given-names></name><name name-style="western"><surname>Quan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Murre</surname><given-names>C.</given-names></name></person-group>
<year>2000</year>
<article-title>Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3.</article-title>
<source>Immunity</source>
<volume>12</volume>: <fpage>17</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">10661402</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearce</surname><given-names>E. L.</given-names></name><name name-style="western"><surname>Mullen</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Martins</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Krawczyk</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Hutchins</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Zediak</surname><given-names>V. P.</given-names></name><name name-style="western"><surname>Banica</surname><given-names>M.</given-names></name><name name-style="western"><surname>DiCioccio</surname><given-names>C. B.</given-names></name><name name-style="western"><surname>Gross</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>C. A.</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Control of effector CD8+ T cell function by the transcription factor Eomesodermin.</article-title>
<source>Science</source>
<volume>302</volume>: <fpage>1041</fpage>&#x02013;<lpage>1043</lpage>.<pub-id pub-id-type="pmid">14605368</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Intlekofer</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Takemoto</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wherry</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Longworth</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Northrup</surname><given-names>J. T.</given-names></name><name name-style="western"><surname>Palanivel</surname><given-names>V. R.</given-names></name><name name-style="western"><surname>Mullen</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Gasink</surname><given-names>C. R.</given-names></name><name name-style="western"><surname>Kaech</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J. D.</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. [Published erratum appears in 2006 <italic>Nat. Immunol.</italic> 7: 133.]</article-title>
<source>Nat. Immunol.</source>
<volume>6</volume>: <fpage>1236</fpage>&#x02013;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">16273099</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventre</surname><given-names>E.</given-names></name><name name-style="western"><surname>Brinza</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schicklin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mafille</surname><given-names>J.</given-names></name><name name-style="western"><surname>Coupet</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Mar&#x000e7;ais</surname><given-names>A.</given-names></name><name name-style="western"><surname>Djebali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jubin</surname><given-names>V.</given-names></name><name name-style="western"><surname>Walzer</surname><given-names>T.</given-names></name><name name-style="western"><surname>Marvel</surname><given-names>J.</given-names></name></person-group>
<year>2012</year>
<article-title>Negative regulation of NKG2D expression by IL-4 in memory CD8 T cells.</article-title>
<source>J. Immunol.</source>
<volume>189</volume>: <fpage>3480</fpage>&#x02013;<lpage>3489</lpage>.<pub-id pub-id-type="pmid">22942430</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agus</surname><given-names>D. B.</given-names></name><name name-style="western"><surname>Surh</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Sprent</surname><given-names>J.</given-names></name></person-group>
<year>1991</year>
<article-title>Reentry of T cells to the adult thymus is restricted to activated T cells.</article-title>
<source>J. Exp. Med.</source>
<volume>173</volume>: <fpage>1039</fpage>&#x02013;<lpage>1046</lpage>.<pub-id pub-id-type="pmid">2022918</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinhardt</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Khoruts</surname><given-names>A.</given-names></name><name name-style="western"><surname>Merica</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>M. K.</given-names></name></person-group>
<year>2001</year>
<article-title>Visualizing the generation of memory CD4 T cells in the whole body.</article-title>
<source>Nature</source>
<volume>410</volume>: <fpage>101</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">11242050</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cruz-Guilloty</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pipkin</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Djuretic</surname><given-names>I. M.</given-names></name><name name-style="western"><surname>Levanon</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lotem</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lichtenheld</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Groner</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name></person-group>
<year>2009</year>
<article-title>Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.</article-title>
<source>J. Exp. Med.</source>
<volume>206</volume>: <fpage>51</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">19139168</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sethna</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Elhanati</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dudgeon</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Callan</surname><given-names>C. G.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Levine</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Mora</surname><given-names>T.</given-names></name><name name-style="western"><surname>Walczak</surname><given-names>A. M.</given-names></name></person-group>
<year>2017</year>
<article-title>Insights into immune system development and function from mouse T-cell repertoires. [Published erratum appears in 2017 <italic>Proc. Natl. Acad. Sci. USA</italic> 144: E2798.]</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>114</volume>: <fpage>2253</fpage>&#x02013;<lpage>2258</lpage>.<pub-id pub-id-type="pmid">28196891</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zehn</surname><given-names>D.</given-names></name><name name-style="western"><surname>King</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bevan</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>E.</given-names></name></person-group>
<year>2012</year>
<article-title>TCR signaling requirements for activating T cells and for generating memory.</article-title>
<source>Cell. Mol. Life Sci.</source>
<volume>69</volume>: <fpage>1565</fpage>&#x02013;<lpage>1575</lpage>.<pub-id pub-id-type="pmid">22527712</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nayar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schutten</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bautista</surname><given-names>B.</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>K.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Enos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Swain</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Welsh</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L. J.</given-names></name></person-group>
<year>2014</year>
<article-title>Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection.</article-title>
<source>J. Immunol.</source>
<volume>192</volume>: <fpage>5881</fpage>&#x02013;<lpage>5893</lpage>.<pub-id pub-id-type="pmid">24835398</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bain</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cravatt</surname><given-names>C. B.</given-names></name><name name-style="western"><surname>Loomans</surname><given-names>C.</given-names></name><name name-style="western"><surname>Alberola-Ila</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Murre</surname><given-names>C.</given-names></name></person-group>
<year>2001</year>
<article-title>Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade.</article-title>
<source>Nat. Immunol.</source>
<volume>2</volume>: <fpage>165</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">11175815</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>August</surname><given-names>A.</given-names></name></person-group>
<year>2006</year>
<article-title>A kinase independent function for Tec kinase ITK in regulating antigen receptor induced serum response factor activation.</article-title>
<source>FEBS Lett.</source>
<volume>580</volume>: <fpage>2691</fpage>&#x02013;<lpage>2697</lpage>.<pub-id pub-id-type="pmid">16631752</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glasmacher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vander Lugt</surname><given-names>B.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Ciofani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Spooner</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Rutz</surname><given-names>S.</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.</article-title>
<source>Science</source>
<volume>338</volume>: <fpage>975</fpage>&#x02013;<lpage>980</lpage>.<pub-id pub-id-type="pmid">22983707</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sebastian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bhullar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ghaffari</surname><given-names>E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Symonds</surname><given-names>A. L. J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name></person-group>
<year>2012</year>
<article-title>The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells.</article-title>
<source>Immunity</source>
<volume>37</volume>: <fpage>685</fpage>&#x02013;<lpage>696</lpage>.<pub-id pub-id-type="pmid">23021953</pub-id></mixed-citation></ref></ref-list></back></article>